|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/21/14 Sonoma Pharmaceuticals, Inc. S-1 60:6.7M Publicease Inc/FA |
Document/Exhibit Description Pages Size
1: S-1 Oculus Innovative Sciences, Inc. HTML 1.24M
2: EX-23.1 Consent of Experts or Counsel HTML 18K
40: R1 Document and Entity Information HTML 44K
30: R2 Condensed Consolidated Balance Sheets HTML 116K
38: R3 Condensed Consolidated Balance Sheets HTML 41K
(Parenthetical)
42: R4 Condensed Consolidated Statements of Comprehensive HTML 113K
Loss (Unaudited)
55: R5 Consolidated Statements of Changes in HTML 91K
Stockholders' Equity
32: R6 Condensed Consolidated Statements of Cash Flows HTML 135K
(Unaudited)
37: R7 1. Organization and Basis of Presentation HTML 84K
27: R8 2. Liquidity and Going Concern HTML 31K
18: R9 3. Summary of Significant Accounting Policies HTML 154K
56: R10 4. Condensed Consolidated Balance Sheets HTML 25K
44: R11 5. Derivative Liabilities HTML 95K
43: R12 6. Commitments and Contingencies HTML 75K
48: R13 7. Stockholders' Equity HTML 53K
49: R14 8. Stock-Based Compensation HTML 114K
47: R15 9. Income Taxes HTML 66K
50: R16 10. Segment and Geographic Information HTML 46K
39: R17 11. Significant Customer Concentrations HTML 25K
41: R18 12. Subsequent Events HTML 29K
46: R19 4. Accounts Receivable (March 2014 note) HTML 32K
60: R20 5. Inventories (March 2014 note) HTML 31K
52: R21 6. Prepaid Expenses and Other Current Assets HTML 24K
(March 2014 note)
34: R22 7. Property and Equipment (March 2014 note) HTML 30K
45: R23 8. Investment in Ruthigen, Inc. (March 2014 note) HTML 50K
36: R24 9. Accrued Expenses and Other Current Liabilities HTML 25K
(March 2014 note)
14: R25 10. Long-Term Debt (March 2014 note) HTML 41K
53: R26 16. Employee Benefit Plan (March 2014 note) HTML 21K
57: R27 3. Summary of Significant Accounting Policies HTML 119K
(Policies)
23: R28 3. Summary of Significant Accounting Policies HTML 39K
(Tables)
22: R29 4. Condensed Consolidated Balance Sheets (Tables) HTML 25K
25: R30 5. Derivative Liabilities (Tables) HTML 46K
26: R31 8. Stock-Based Compensation (Tables) HTML 60K
28: R32 10. Segment and Geographic Information (Tables) HTML 31K
13: R33 2. Liquidity and Financial Condition (Details HTML 29K
Narrative)
51: R34 3. Summary of Significant Accounting Policies HTML 22K
(Details - Potentially Dilutive Securities)
33: R35 3. Summary of Significant Accounting Policies - HTML 27K
Financial liabilities (Details)
35: R36 3. Summary of Significant Accounting Policies HTML 22K
(Details Narrative)
16: R37 4. Condensed Consolidated Balance Sheets (Details HTML 21K
- Inventories)
59: R38 5. Derivative Liabilities (Details - Valuation HTML 43K
Assumptions)
9: R39 5. Derivative Liabilities (Details - Changes in HTML 26K
fair value)
29: R40 6. Commitments and Contingencies (Details - HTML 34K
Assumptions)
54: R41 6. Commitments and Contingencies (Details HTML 39K
Narrative)
15: R42 7. Stock holders' Equity (Details Narrative) HTML 30K
21: R43 8. Stock-Based Compensation (Details - Allocated HTML 23K
Share-Based Compensation Expense)
24: R44 8. Stock-Based Compensation (Details - Options HTML 62K
Outstanding)
31: R45 8. Stock-Based Compensation (Details Narrative) HTML 33K
12: R46 10. Segment and Geographic Information (Details) HTML 22K
17: R47 10. Segment and Geographic Information (Details HTML 25K
Narrative)
10: R48 11. Significant Customer Concentrations (Details HTML 23K
Narrative)
58: XML IDEA XML File -- Filing Summary XML 91K
11: EXCEL IDEA Workbook of Financial Reports XLSX 201K
20: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 889K
3: EX-101.INS XBRL Instance -- ocls-20140930 XML 1.41M
5: EX-101.CAL XBRL Calculations -- ocls-20140930_cal XML 136K
6: EX-101.DEF XBRL Definitions -- ocls-20140930_def XML 281K
7: EX-101.LAB XBRL Labels -- ocls-20140930_lab XML 671K
8: EX-101.PRE XBRL Presentations -- ocls-20140930_pre XML 502K
4: EX-101.SCH XBRL Schema -- ocls-20140930 XSD 112K
19: ZIP XBRL Zipped Folder -- 0001019687-14-004450-xbrl Zip 143K
EXHIBIT 23.1
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT
We consent to the inclusion in this Registration Statement of Oculus Innovative Sciences, Inc. on Form S-1 of our report dated June 30, 2014 with respect to our audits of the consolidated financial statements of Oculus Innovative Sciences, Inc. and Subsidiaries as of March 31, 2014 and 2013 and for the years then ended, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.
/s/ Marcum LLP
New York, NY
| This ‘S-1’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/21/14 | |||
| 6/30/14 | 10-K, 10-Q | |||
| 3/31/14 | 10-K, 3 | |||
| 3/31/13 | 10-K | |||
| List all Filings | ||||